Significant Ownership of Funicular Funds, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Funicular Funds, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Jacob Ma-Weaver - Managing Member of the General Partner
- Manager location
- San Francisco, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Funicular Funds, LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Funicular Funds, LP
Significant Ownership of Funicular Funds, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NETD | Nabors Energy Transition Corp. II | Class A Ordinary Shares, $0.0001 par value | 56% | $30,739,247 | -$5,103,000 | 2,710,692 | -14% | Funicular Funds, LP | 17 Nov 2025 |
| SYBX | SYNLOGIC, INC. | Common Stock, par value $0.001 per share | 28% | $1,987,331 | 3,312,219 | Funicular Funds, LP | 02 Apr 2026 | ||
| ATCH | AtlasClear Holdings, Inc. | Common Stock, par value $0.0001 per share | 9.9% | $9,248,539 | +$8,750,331 | 12,669,232 | +1756% | Funicular Funds, LP | 10 Oct 2025 |
| KTTA | Pasithea Therapeutics Corp. | Common Stock, par value $0.0001 | 7.4% | $1,416,424 | 1,839,512 | Funicular Funds, LP | 15 Apr 2026 | ||
| RNTX | Rein Therapeutics, Inc. | Common Stock, par value $0.001 | 6.7% | $6,753,500 | 5,195,000 | Funicular Funds, LP | 01 May 2026 | ||
| IMA | ImageneBio, Inc. | Common Stock, $0.001 par value | 5.8% | $4,211,322 | 643,933 | Funicular Funds, LP | 29 Dec 2025 | ||
| AMWL | American Well Corp | Class A Common Stock, par value $0.01 | 5.5% | $3,951,436 | 810,551 | Funicular Funds, LP | 16 Jan 2026 | ||
| ABEO | ABEONA THERAPEUTICS INC. | Common Stock, par value $0.01 | 5.3% | $14,916,352 | 3,007,329 | Funicular Funds, LP | 27 Mar 2026 | ||
| NSRX | Nasus Pharma Ltd | Ordinary Shares | 5.2% | $3,309,730 | 612,913 | Funicular Funds, LP | 31 Mar 2026 | ||
| ACOG | Alpha Cognition Inc. | Common Stock, no par value | 5.1% | $6,632,745 | +$324,483 | 1,114,747 | +5.1% | Funicular Funds, LP | 11 Feb 2026 |
Schedules 13D/G Reported by Funicular Funds, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.